Craft

AroCell

Stock Price

KR0.5

2024-10-29

Market Capitalization

KR117.5 M

2024-10-29

Revenue

KR57.4 M

FY, 2024

AroCell Summary

Company Summary

Overview
AroCell AB is an in vitro diagnostics company focusing on the monitoring of hematological malignancies, breast cancer, and other solid tumors. It is involved in the development, manufacture, and sale of products for the measurement of human Thymidine Kinase 1 (TK1) concentration in blood.
Type
Public
Status
Active
Founded
2003
HQ
Uppsala, SE | view all locations
Website
https://arocell.com/
Cybersecurity rating
Sectors

Key People

  • Peter Löwendahl

    Peter Löwendahl, Senior Director Regulatory Affairs Director

    • Eva Nordström

      Eva Nordström, Director

      • Anders Hultman

        Anders Hultman, CFO

        LocationsView all

        1 location detected

        • Uppsala, Uppsala län HQ

          Sweden

          Virdings allé 32B

        AroCell Financials

        Summary Financials

        Revenue (FY, 2024)
        kr57.4M
        Gross profit (FY, 2024)
        kr13.4M
        Net income (FY, 2024)
        (kr42.4M)
        Cash (FY, 2024)
        kr47.8M
        EBIT (FY, 2024)
        (kr43.4M)

        Footer menu